The present invention relates to novel substituted indolyl compounds of formula (I), their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, their derivatives, their stereoisomers, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. This invention also relates to the novel intermediates involved therein and process of their preparation. These compounds are useful in the treatment of various disorders that are related to 5-HT6 receptor functions.
本发明涉及公式(I)的新型取代
吲哚基化合物,其衍
生物,其立体异构体,其药学上可接受的盐和含有它们的药学上可接受的组合物。本发明还涉及上述新型化合物,其衍
生物,其立体异构体,其药学上可接受的盐和含有它们的药学上可接受的组合物的制备方法。本发明还涉及其中涉及的新型中间体及其制备方法。这些化合物在治疗与5-HT6受体功能相关的各种疾病中有用。